CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced it has finalized its acquisition of Retina Consultants of America (RCA), a major management services organization for retina specialists. The transaction, valued at $4.4 billion, marks a significant step in Cencora’s strategy to strengthen its position in the specialty healthcare sector.
Cencora now holds an 85% stake in RCA, with the remaining equity retained by certain physicians and members of RCA’s management team. The acquisition provides Cencora with expanded MSO solutions, enhancing its ability to deliver value to physicians and patients alike.
The deal also aligns with Cencora’s broader mission of advancing specialty healthcare by leveraging the combined expertise of both organizations. The move is expected to bolster Cencora’s specialty services and drive differentiated care across its network.
Fiscal Year 2025 Guidance Boosted
Following the acquisition, Cencora has updated its fiscal year 2025 earnings guidance. The company now projects adjusted diluted earnings per share (EPS) to range between $15.15 and $15.45, an increase from the previous forecast of $14.80 to $15.10.
This upward revision reflects not only the anticipated contributions from RCA but also sustained growth momentum within Cencora’s U.S. Healthcare Solutions division.
The RCA acquisition aims to strengthen Cencora’s position in the specialty healthcare market, which is expected to see significant growth in the coming years. With a focus on innovation and cutting-edge technology, Cencora is well-positioned to capitalize on this trend.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.